Clinical Trials Sponsored by SIRN

Total 355 results

Sir Mortimer B. Davis - Jewish General Hospital

Recruiting

Management of Castration-Resistant Prostate Cancer With Oligometastases (PCS IX)

Castration-resistant Prostate Cancer Patients With Oligometastases

Canada
Sir Mortimer B. Davis - Jewish General Hospital

Enrolling by invitation

Prostate Cancer Patient Management With 18F-DCFPyL PET/CT

Prostate Cancer

Canada
Sir Mortimer B. Davis - Jewish General Hospital

Completed

Exploring the Effect of Video Interventions on Intentions for Continued COVID-19 Vaccination

COVID-19 | Vaccine Refusal

Canada
Sir Mortimer B. Davis - Jewish General Hospital

Completed

Metabolic Change in Prostate Cancer Bone Metastases on 68Ga-HBED-CC-PSMA PET/CT Following Radium-223 Therapy

Prostate Cancer

Canada
Massachusetts General Hospital
Sir Charles Gairdner Hospital

Completed

Midodrine for the Treatment of Refractory Hypotension

Critical Illness | Hypotension

United States, Australia
Sir Mortimer B. Davis - Jewish General Hospital

Active, not recruiting

Hypofractionated, Dose Escalation Radiotherapy for High Risk Adenocarcinoma of the Prostate

Prostate Cancer

Canada
Dr Nitin Sethi

Completed

Evaluation of Automated Propofol Delivery in Patients Undergoing Thoracic Surgery

Surgery | Thoracic Diseases

India
Sir Mortimer B. Davis - Jewish General Hospital

Completed

The Safety and Efficacy of 18F-Fluoromethylcholine (18F-FCH) PET/CT in Prostate Cancer

Prostate Cancer

Canada
Sir Mortimer B. Davis - Jewish General Hospital

Completed

Correlation Between SUV on 68Ga-HBED-CC-PSMA and Gleason Score in Prostate Cancer

Prostate Cancer

Canada
Sir Mortimer B. Davis - Jewish General Hospital

Completed

Correlation Between SUV on 18F-Fluorocholine PET/CT and Gleason Score in Prostate Cancer

Prostate Cancer

Canada
Zhejiang University
Sir Run Run Shaw Hospital

Unknown

Study Evaluating the Efficacy of Thick Shell Mussel Lipid Extract in Chinese Subjects With Rheumatoid Arthritis

Rheumatoid Arthritis

China
Fresenius Medical Care Deutschland GmbH
Siro Clinpharm Germany GmbH

Completed

Non-interventional Study to Evaluate the Ease of Reaching Individual Goals in Serum Phosphorus (Steering) (Steering)

ESRD | Hyperphosphataemia

United Kingdom, Spain, Denmark, Germany
Ozkan Sir
Ataturk University

Recruiting

The Effect of Cold Spray Applied Before Local Anaesthesia (EffectofCold)

Coronary Artery Disease | Pain | Anxiety

Turkey
Sir Mortimer B. Davis - Jewish General Hospital

Recruiting

Aggressive Smoking Cessation Trial (ASAP) (ASAP)

Acute Coronary Syndrome

Canada
Sir Mortimer B. Davis - Jewish General Hospital

Recruiting

Management of Oligoprogressive Castration Resistant Prostate Cancer (PCS X)

Castration-resistant Prostate Cancer | Metastatic Prostate Cancer

Canada
Sir Mortimer B. Davis - Jewish General Hospital

Recruiting

No Surgery Trial / Two Dose-escalation Strategies (Morpheus)

Stage II Rectal Cancer

Canada
Sir Mortimer B. Davis - Jewish General Hospital

Recruiting

The Predictive Value of Coexisting TMPRSS2-ERG Gene Fusion and PTEN Deletion in Prostate Cancer Patients With Biochemical Failure Status Post Salvage or Radical Radiation Therapy

Prostate Cancer

Canada
Sir Mortimer B. Davis - Jewish General Hospital

Recruiting

GRID Therapy as Palliative Radiation for Patients With Advanced and Symptomatic Tumors

Patients With Symptomatic or Bulky Tumors (More Than 8 cm) or With Tumors Resistant to Radiation

Canada
Sir Mortimer B. Davis - Jewish General Hospital

Recruiting

Comparative Study of Use of Alpha-Blockers to Treat Symptoms in Prostate Cancer Patients Undergoing Radiation Therapy

Prostate Cancer | Urinary Problems

Canada
Sir Mortimer B. Davis - Jewish General Hospital

Enrolling by invitation

Fluorocholine PET/CT Basket Trial

Fluorocholine PET/CT

Canada
Nitin Sethi, DNB

Completed

Quality of Recovery After Robotic Surgery

Patients Undergoing Robotic Surgery

India
Sir Mortimer B. Davis - Jewish General Hospital

Terminated

SUV on PSMA PET/CT in Non-Prostate Tumors

Cancer

Canada
Sir Mortimer B. Davis - Jewish General Hospital

Withdrawn

Effect of Hydroxychloroquine in COVID-19 Positive Pregnant Women (HyPreC)

COVID-19 | Pregnant Women | SARS-CoV-2 | Hydroxychloroquine
Sir Mortimer B. Davis - Jewish General Hospital

Unknown

Routine Or Selective Stress Testing After Revascularization: ROSSTAR Trial RCT Outline (ROSSTAR)

Coronary Artery Disease | Coronary Heart Disease
Sir Mortimer B. Davis - Jewish General Hospital

Unknown

Prospective Evaluation of Long-term Outcomes After Pulmonary Embolism (ELOPE)

Pulmonary Embolism

Canada
Centre Hospitalier du Centre du Valais
University of Lausanne Hospitals; Research Unit CHCVs Hôpital de Sion Switzerland and other collaborators

Unknown

Effects of High Cut-off (HCO) Hemodialysis on Central Memory CD4+ T and Treg Cells in Patients With End-stage Kidney Disease

End-stage Kidney Disease | CD4 T Cells | Central Memory T Cells | Regulatory T Cells | Uremic Toxins

Switzerland
Università degli Studi del Piemonte Orientale "Amedeo...
Ipsen; Azienda Ospedaliero Universitaria Maggiore della Carita; SIRN

Unknown

CLINICAL EFFECT OF BOTULINUM TOXIN TYPE A IN TREATMENT OF SPASTICITY

Multiple Sclerosis | Brain Injuries | Spinal Cord Injuries | Spasticity

Italy
Zhangfa Song

Not yet recruiting

Chemotherapy Plus Bevacizumab and Anti-PD-1 Followed by Induction Therapy of Chemotherapy Plus Bevacizumab

Metastatic Colorectal Cancer | MSS

China
Sir Mortimer B. Davis - Jewish General Hospital

Not yet recruiting

Neuromuscular Electrical Stimulation for Children With Dysphagia

Dysphagia
Sir Mortimer B. Davis - Jewish General Hospital

Recruiting

Novel Robotic Prostatectomy Technique for Early Urinary Continence (TRS-RALP)

Prostate Cancer

Canada
Sir Mortimer B. Davis - Jewish General Hospital

Not yet recruiting

Telo Genomics Technology to Detect & Profile Multiple Myeloma MRD (TELO - DMRD)

Multiple Myeloma
Sir Mortimer B. Davis - Jewish General Hospital

Not yet recruiting

Niraparib in High-grade Endometrial Cancer Trial (NIREC)

Endometrial Cancer | Uterine Neoplasm | Serous Adenocarcinoma
Sir Mortimer B. Davis - Jewish General Hospital

Not yet recruiting

The Predictive Value of TMPRSS2-ERG Fusion in High Risk Prostate Cancer Patient

Prostate Cancer
Sir Mortimer B. Davis - Jewish General Hospital

Recruiting

Comparative Study of Radiotherapy Treatments to Treat High Risk Prostate Cancer Patients

Prostate Cancer

Canada
Sir Mortimer B. Davis - Jewish General Hospital

Active, not recruiting

The MUFFIN-PTS Trial (MUFFIN-PTS)

Post-Thrombotic Syndrome

Canada
Sir Mortimer B. Davis - Jewish General Hospital

Completed

68Ga-PSMA PET/CT in Prostate Cancer

Prostate Cancer

Canada
Sir Mortimer B. Davis - Jewish General Hospital

Terminated

Two TraCer PositROn EmiSSion Tomography ComBination for Efficacy EstimatiOn of Prostate Specific Membrane Antigen Radioligand Therapy in Patients With Metastatic Prostate Cancer (CROSSBOW)

Prostatic Neoplasms | Prostate Cancer | Metastatic Prostate Cancer | Prostate Adenocarcinoma | Metastatic Prostatic Adenocarcinoma | Metastatic Prostate Carcinoma in the Soft Tissue

Canada
Dr Nitin Sethi

Completed

Automated Closed Loop Propofol Anaesthesia Versus Desflurane Inhalation Anaesthesia In Bariatric Surgery

Anesthesia; Bariatric Surgery

India
Sir Mortimer B. Davis - Jewish General Hospital

Terminated

Fesoterodine on Urgency Episodes in Parkinson's Disease Population

Urinary Bladder, Overactive | Parkinson Disease

Canada
Sir Mortimer B. Davis - Jewish General Hospital

Completed

Correlation Between SUV on 18F-DCFPyL PET/CT and Gleason Score in Prostate Cancer

Prostate Cancer

Canada
Dr Nitin Sethi

Completed

Effect of Dexmedetomidine on Propofol Requirement During Anesthesia

Anesthesia

India
Dr. Ashish Kumar

Completed

Prospective Study of Profile of Hepatic Osteodystrophy in Patients With Non-Choleastatic Liver Cirrhosis and Impact of Bisphosphonate Supplementation

Cirrhosis

India
Wei Zhou

Unknown

Parenteral Fish Oil in Major Laparoscopic Abdominal Surgery

Liver Tumor | Gastric Tumor | Pancreatic Tumor

China
Sir Mortimer B. Davis - Jewish General Hospital

Completed

Effect of Fructose on Colonic Microflora (MEF)

Healthy

Canada
Sir Mortimer B. Davis - Jewish General Hospital

Unknown

Efficacy of 18-Months of Antidepressive Medication Plus CBT or Dynamic or Supportive Psychotherapy for Recurrent Major Depression

Major Depression

Canada
Shanghai Juncell Therapeutics
Sir Run Run Shaw Hospital

Recruiting

A Clinical Study on TIL for the Treatment of Advanced Solid Tumors

Advanced Solid Tumor | Treatment Side Effects | Effects of Immunotherapy | Tumor Infiltrating Lymphocytes

China
Sir Mortimer B. Davis - Jewish General Hospital
Abbott

Recruiting

Adjuvant Androgen Suppression Plus Radiation Therapy for High-Risk Localized Adenocarcinoma Prostate

Adenocarcinoma of the Prostate

Canada
University of Edinburgh
Sir Jules Thorn Charitable Trust

Active, not recruiting

Early Valve Replacement Guided by Biomarkers of LV Decompensation in Asymptomatic Patients With Severe AS (EVoLVeD)

Aortic Valve Stenosis | Hypertrophy, Left Ventricular

United Kingdom
Sir Mortimer B. Davis - Jewish General Hospital
Sanofi

Completed

A Study on the Timing of FOLFOX for Patients With Operable, Node Positive Rectal Cancer

Operable T2-3N+M0 Rectal Cancer (Stage III)

Canada
North Bristol NHS Trust
Sir Halley Stewart Trust

Completed

Repeat Infusion of Autologous Bone Marrow Cells in Multiple Sclerosis (SIAMMS-II)

Multiple Sclerosis

United Kingdom

Clinical Trials Sponsored by SIRN

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Senegal

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations